Record Attendance Expected At UBM's Chinese Pharma Events

By Cphi China, PRNE
Sunday, April 25, 2010

AMSTERDAM, April 26, 2010 - Continued double digit growth in the Chinese pharmaceutical industry is
reflected in record visitor pre-registration levels and a sell-out of
exhibition space at this year's UBM International Media China events - CPhI,
ICSE, P-MEC and BioPh - which will run from June 2-4 at the Shanghai New
International Expo Centre.

Focusing on intermediates and APIs, CPhI China, along with co-located
events - P-MEC for equipment, machinery and technology; ICSE for Contract
Services; and, making its debut in China, BioPh for the biopharma sector - is
the largest annual networking event for the Asian pharmaceutical community
and is expected to attract over 20,000 visitors, including 7,000 from outside
of China.

Projected to be the third largest pharma market globally by 2011 and
second by 2020, China is both a large producer and consumer of medicines,
making it an attractive market in terms of both sourcing and sales.
Additional stimuli, such as changes to local GMP standards, which are being
revised in 2010 to be more in line with international ones, are also making
China increasingly appealing for Western visitors to the events, looking to
access the many outsourcing and production efficiency partnering
opportunities available in China.

The dramatic expansion of China's pharma industry is illustrated by the
exponential growth experienced by UBM's portfolio of China events. The
inaugural CPhI China in 2001 attracted under 200, mainly domestic exhibitors
and 8000 visitors, while this year, the combined events portfolio will host
1,597 Chinese exhibitors and 100 international exhibitors from countries
including India, the US, Germany and the UK.

"Within the last 50 years life expectancy in China has almost doubled,"
commented Eliane van Doorn, UBM International Media's Group Director for
Pharma events. "With the burgeoning middle-class population aging, rapidly
urbanising and adopting Western lifestyles, the Chinese market presents
diverse, exciting opportunities for both domestic and international

Now in its tenth year, CPhI China was joined by ICSE China in 2005, P-MEC
China in 2006 and BioPh China in 2010. The events benefit from the valuable
support of the China Chamber of Commerce for Import and Export of Medicines
and Health Products (CCCMHPIE) and are organised in conjunction with UBM
International Media's sister organisation, UBM Sinoexpo.

UBM International Media's CPhI family of events for the pharma
ingredients and services sector includes Worldwide (Europe - October); Japan
(April); South America (August) and India (December). Free on-line
registration is available at: and

Notes for Editors:

UBM International Media operates market-leading global exhibition brands
and their complementary media products.

The CPhI pharmaceutical ingredients and related sector exhibitions
currently number over 15 highly-regarded annual events. The portfolio also
includes Informex (specialty chemicals), Food Ingredients, HBA (health &
beauty industry) and Sea Trade (cruise industry).

Worldwide locations for its events include China, India, Japan, North
, Brazil, Africa and Europe. More than 330,000 business professionals
and marketers visit UBM exhibitions each year. The exhibitions portfolio is
managed from Holland. UBM International Media has approximately 1,200
employees in the UK, US, Asia and Europe. See

Media Enquiries: Impress PR, Europe: Richard Kerns, richard at, +44-161-728-5880, or North America: Mark Button, mark at, Tel +1-503-616-3817; or Company Enquiries: UBM International Media, Rob Sahi (CPhI), +31-20-40-99-5561, or Ian O'Malley (ICSE, P-MEC, BioPh), +31-20-40-99-5526

will not be displayed